<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>cancer de prostata &#8211; Video Raportul de Gardă</title>
	<atom:link href="https://video.raportuldegarda.ro/tag/cancer-de-prostata/feed/" rel="self" type="application/rss+xml" />
	<link>https://video.raportuldegarda.ro</link>
	<description></description>
	<lastBuildDate>Sun, 25 Aug 2019 07:58:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.9.3</generator>
	<item>
		<title>#ASCO19. Conf. Dr. Şerban Negru: Noi opțiuni în cancerul de prostată. Cancer pulmonar: pembrolizumab</title>
		<link>https://video.raportuldegarda.ro/lider-de-opinie/asco19-serban-negru-cancer-prostata-cancer-pulmonar-pembrolizumab/</link>
					<comments>https://video.raportuldegarda.ro/lider-de-opinie/asco19-serban-negru-cancer-prostata-cancer-pulmonar-pembrolizumab/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sun, 25 Aug 2019 07:57:58 +0000</pubDate>
				<category><![CDATA[Imuno-oncologia]]></category>
		<category><![CDATA[Lider de opinie]]></category>
		<category><![CDATA[Medicina personalizată]]></category>
		<category><![CDATA[ASCO19]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer de prostata]]></category>
		<category><![CDATA[cancer pulmonar]]></category>
		<category><![CDATA[imunoterapii]]></category>
		<category><![CDATA[pembrolizumab]]></category>
		<guid isPermaLink="false">https://video.raportuldegarda.ro/?p=1138</guid>

					<description><![CDATA[Urmăriţi o discuţie chiar de la Olimpiada Oncologiei, #ASCO19, cu Conf. Dr. Şerban Negru, medic oncolog şi Dr. Bianca Cucos, editor #RaportuldeGarda, despre noutăţile din oncologie. La fel ca şi în ultimii ani, imunoterapiile şi terapiile ţintite se impun ca standarde de tratament în tot mai multe neoplasme, iar rezultatele studiilor vin să confirme acest [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>Urmăriţi o discuţie chiar de la Olimpiada Oncologiei, <a class="yt-simple-endpoint style-scope yt-formatted-string" spellcheck="false" href="https://www.youtube.com/results?search_query=%23ASCO19">#ASCO19</a>, cu Conf. Dr. Şerban Negru, medic oncolog şi Dr. Bianca Cucos, editor <a class="yt-simple-endpoint style-scope yt-formatted-string" spellcheck="false" href="https://www.youtube.com/results?search_query=%23RaportuldeGarda">#RaportuldeGarda</a>, despre noutăţile din oncologie. La fel ca şi în ultimii ani, imunoterapiile şi terapiile ţintite se impun ca standarde de tratament în tot mai multe neoplasme, iar rezultatele studiilor vin să confirme acest lucru.</p>
<p><a href="https://raportuldegarda.ro" target="_blank" rel="noopener noreferrer">Vezi site</a></p>
<p><a href="https://www.youtube.com/channel/UCM7NUk8i6jr-yHXLJ8IuXAw?sub_confirmation=1" target="_blank" rel="noopener noreferrer">Abonare YouTube</a></p>
<p><a href="https://www.instagram.com/raportuldegarda/" target="_blank" rel="noopener noreferrer">Instagram</a></p>
]]></content:encoded>
					
					<wfw:commentRss>https://video.raportuldegarda.ro/lider-de-opinie/asco19-serban-negru-cancer-prostata-cancer-pulmonar-pembrolizumab/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
